Salwa Almefareh: Bringing Life-Changing Haemophilia Care to Patients Worldwide
Salwa Almefareh, Regulatory Affairs Specialist at Roche Middle East, Mohamed Naser Al-Hajery and Sons Ltd., shared a post on LinkedIn:
“True innovation in haemophilia A extends beyond scientific discovery, it is realized when innovation reaches the patients who need it most.
At Roche, we believe meaningful progress is driven by strong partnerships and a shared commitment to improving global health.
Our long-term support of the World Federation of Hemophilia WFH Humanitarian Aid Program reflects this commitment, helping expand access to care for people living with inherited bleeding disorders in low- and middle-income countries.
By working together across the healthcare ecosystem, we can help reduce disparities in care, strengthen health systems, and create a future where more people with haemophilia have the opportunity to receive timely, life-changing treatment.
Learn how collaboration continues to shape the future of haemophilia care.”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 08:43Joy Duemke: Optimizing Stem Cell Collection for Gene Therapy Success
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026